Life Expectancy in Minorities - How Can Pharma React?

Over the past 15 years, on average, racial and ethnic diversity in multiple US regions has increased by 1% to 5%.

JAMA study argues that addressing social determinants of health is crucial to narrowing life expectancy gaps between high- and low-income countries.

Closing the gender gap in pharma—and how we get there together.

Amy West, Head of US Digital Health & Innovation Strategy at Novo Nordisk, shares her insights on fostering collaboration, embracing change, and her compelling vision to revolutionize digital transformation and innovation in the field of healthcare.

Morton discusses his transition from working as a urologist to the C-suite.

How pharma companies can make justice and integrity a priority.